Sub Banner Image

BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?

Equities

Zacks Investment Research

·

June 13, 2025

·

Barchart

Boston Scientific’s BSX Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) conditions using innovative, less invasive technologies. The company is strategically positioned to benefit from the expanding global endoscopy devices market through its strong innovation pipeline and well-diversified product offerings. Per an...

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.